Caspian Journal of Internal Medicine
Babol University of Medical Sciences
Wed, Sep 18, 2024
[Archive]
Volume 10, Issue 3 (6-2019)
Caspian J Intern Med 2019, 10(3): 339-342 |
Back to browse issues page
Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
Mohammadi Kebar Y, Avesta L, Habibzadeh A, Hemmati M. Libman-Sacks endocarditis in patients with systemic lupus erythematosus with secondary antiphospholipid syndrome. Caspian J Intern Med 2019; 10 (3) :339-342
URL: http://caspjim.com/article-1-1597-en.html
URL: http://caspjim.com/article-1-1597-en.html
Department of Internal Medicine, Ardabil University of Medical Sciences, Ardabil, Iran , afshin.habibzadeh@gmail.com
Abstract: (6755 Views)
Background: Libman-Sacks endocarditis (LSE) is characterized by sterile lesions that commonly affect the aortic and mitral heart valves. Antiphospholipid syndrome (APS) and systemic lupus erythematosus (SLE) have been associated with LSE. Cardiac manifestations including LSE could be interrelated with other manifestations and early diagnosis could help in preventing further complications.
Case presentation: Here, we report three cases of LSE in SLE patients with secondary APS. All patients presented with neurological manifestations and LSE was diagnosed by Transesophageal echocardiography (TEE). All three patients were treated for the underlying disease and also received anticoagulant therapy.
Conclusion: In all patients with SLE and secondary APS, LSE should be considered if a patient manifests any evidence of neurologic involvement.
Case presentation: Here, we report three cases of LSE in SLE patients with secondary APS. All patients presented with neurological manifestations and LSE was diagnosed by Transesophageal echocardiography (TEE). All three patients were treated for the underlying disease and also received anticoagulant therapy.
Conclusion: In all patients with SLE and secondary APS, LSE should be considered if a patient manifests any evidence of neurologic involvement.
Type of Study: case report |
Subject:
Reumatology
Received: 2018/09/3 | Accepted: 2018/12/11 | Published: 2019/07/27
Received: 2018/09/3 | Accepted: 2018/12/11 | Published: 2019/07/27
Send email to the article author
| Rights and permissions | |
 |
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |
